53 results on '"Hurst, John R."'
Search Results
2. Quality and compliance to home-based spirometry in COPD patients
3. Changes in sputum bacterial density in people with bronchiectasis: BRONCH UK Study data
4. Small Airways Disease and Emphysema (Assessed by High-Resolution CT) and Symptom Burden in COPD
5. Relationship between baseline rescue medication use and reductions in COPD exacerbation rates: a subgroup analysis of the ETHOS trial
6. Domiciliary monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and/or progression: a systematic review
7. Research priorities for airway diseases in “long COVID”
8. Evidence-implementation gaps in low- and middle-income countries' COPD guidelines
9. Predictive modelling of COPD exacerbation rates using baseline risk factors
10. Upper Respiratory Symptoms in Patients with Chronic Obstructive Pulmonary Disease
11. Late Breaking Abstract - Arterial Stiffness and Cardiovascular Risk in hospitalised COPD patients
12. Patient pathway modelling using Discrete Event Simulation to reduce readmissions in COPD
13. Assessment of Treatment Response in Granulomatous Lymphocytic Interstitial Lung Disease (GLILD)
14. Nutritional Supplementation during Pulmonary Rehabilitation in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review
15. Late Breaking Abstract - Characteristics and treatment of patients with comorbid COPD and heart failure
16. Airway tapering in bronchiectatic and healthy airways
17. Cardiovascular risk and exercise capacity in COPD
18. A randomised crossover trial investigating the effect of a portable positive pressure ventilation device on exercise tolerance in patients with COPD
19. Impact of Physical Frailty on Pulmonary Rehabilitation and Hospitalisation in COPD
20. Disease progression patterns in COPD
21. Investigation of shortened lung clearance index (LCI) in the Bronch-UK Clinimetrics study.
22. Persistent blood eosinophilia and COPD exacerbation risk after ICS withdrawal from triple therapy in the SUNSET study
23. Tapering analysis of airways with bronchiectasis
24. A comparison of peripheral arterial tone technology with limited polygraphy to diagnose obstructive sleep apnoea in UK
25. LATE-BREAKING ABSTRACT: Improving admission free survival with home mechanical ventilation (HMV) and home oxygen therapy (HOT) following life threatening COPD exacerbations: HoT-HMV UK Trial NCT00990132
26. Long-acting bronchodilators (LABDs) and major adverse cardiac events (MACE) in patients with COPD: A pooled analysis of 12 randomised trials
27. Tapering Analysis of Airways with Bronchiectasis.
28. Nasal And Systemic Inflammation, And Nasal Mucociliary Clearance In Obstructive Sleep Apnoea Patients Using Nasal Continuous Positive Airway Pressure (nCPAP)
29. The Time-Course Of Changes In Arterial Stiffness During COPD Exacerbations
30. Dose Response Of Continuous Positive Airway Pressure (CPAP) On Inflammatory Responses In Human Bronchial Epithelial Cells In Vitro
31. Dose Response Of Nasal Continuous Positive Airway Pressure (nCPAP) On Nasal Mucociliary Clearance And Upper Airway Symptoms In Healthy Subjects
32. Characterization Of Proteinase Activated Receptor 1 (PAR-1) Expression In Primary Human Bronchial Epithelial Cells
33. Relationships Between COPD Exacerbation Frequency And Arterial Stiffness
34. Daily Peak Expiratory Flow Moving Average Crossing Density And Exacerbation Frequency In COPD
35. Utility Of The COPD Assessment Test (CAT) To Evaluate Severity Of COPD Exacerbations
36. Dose Response Of Nasal Continuous Positive Airway Pressure (nCPAP) On Airway Inflammatory Responses In Healthy Subjects
37. Effect Of Nasal Continuous Positive Airway Pressure (ncpap) On Nasal Mucociliary Clearance And Upper Airway Symptoms In Healthy Subjects
38. Health Status In Patients With Chronic Obstructive Pulmonary Disease And Comorbid Ischaemic Heart Disease
39. Utility Of The COPD Assessment TestTM (CAT) In Stable COPD
40. Factors Associated With Change In COPD Exacerbation Frequency Phenotype
41. Effect Of Nasal Continuous Positive Airway Pressure (NCPAP) On Airway And Systemic Inflammation In Normal Subjects
42. The COPD Assessment TestTM (CAT) Can Detect Changes In Health Status During COPD Exacerbations
43. Effect Of Time Outdoors And Hours Of Daylight On Vitamin D Levels In COPD
44. Risk Factors And Mortality Associated With Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Exacerbations During The 3-Year Follow-Up In The Evaluation Of COPD Longitudinally To Identify Predictive Surrogate Endpoints (Eclipse) Cohort
45. SERPINA1 11478G>A Variant, Serum A1-Antitrypsin, Exacerbation Frequency And FEV1 Decline In COPD
46. Time Course And Phenotype Of COPD Exacerbations
47. Prevalence Of Herpes Zoster In COPD And Relationships With Inhaled Corticosteroids, Exacerbation Frequency And FEV1
48. Poor Health Status Independently Associated With Longer Exacerbation Recovery In COPD
49. Effect Of Exacerbations Frequency On Body Mass Index And Appetite In COPD
50. Occurrence And Descriptors Of Severe COPD Exacerbations In The ECLIPSE Cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.